Schizoaffective Disorders Completed Phase 4 Trials for Olanzapine (DB00334)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02307396Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsTreatment
NCT01609153Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyTreatment
NCT00202293Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesTreatment
NCT00981526Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With SchizophreniaTreatment
NCT01248195Optimization of Treatment and Management of Schizophrenia in EuropeTreatment
NCT00330863Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyTreatment
NCT00007774To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
NCT00034801Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaTreatment
NCT00090012Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderTreatment
NCT00100776Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderTreatment
NCT00190749Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderTreatment
NCT00303602Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)Treatment
NCT00337662Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaTreatment
NCT00423878Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderTreatment
NCT00918021Polypharmacy in Clozapine-resistant SchizophreniaTreatment
NCT02137993Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaTreatment